Debates and Roundtables
Expert Roundtable: Are All EGFR-Sensitive Mutations Equal or Should They Be Approached Differently?
07/14/2021
In this Oncology Learning Network exclusive virtual roundtable, moderated by Edgardo Santos, MD, Florida Precision Oncology, Aventura, a panel of experts discuss EGFR-sensitive alterations in lung cancer, highlighting overall survival in the EGFR-TKI era, biological differences between alterations, comutations, and synergistic effects between the EGFR and VEGF pathway.
The panel included Luis Raez, MD, Memorial Healthcare System, Pembroke Pines, Florida; Federico Albrecht, MD, Miami Cancer Institute, Florida; Mark Socinski, MD, Advent Health, Orlando, Florida; and John Heymach, MD, PhD, MD Anderson Cancer Center, Houston, Texas.
